TNSN01013A1 - Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composes - Google Patents
Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composesInfo
- Publication number
- TNSN01013A1 TNSN01013A1 TNTNSN01013A TNSN01013A TNSN01013A1 TN SN01013 A1 TNSN01013 A1 TN SN01013A1 TN TNSN01013 A TNTNSN01013 A TN TNSN01013A TN SN01013 A TNSN01013 A TN SN01013A TN SN01013 A1 TNSN01013 A1 TN SN01013A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- treatment
- dicarboxylates
- diabetes
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
L’INVENTION CONCERNE DES PRODUITS DE SOLVATATION AVEC DES ALCOOLS ET L’EAU DU SEL MONOCALCIQUE D’ACIDE 6-(5- CARBOXY-5-METHYL-HEXYLOXY)-2,2-DIMETHYL-HEXANOIQUE, QUI SONT CRISTALLINS ET QUI REPONDENT A LA FORMULE : DANS LAQUELLE R1 REPRESENTE H OU UN GROUPE ALKYLE INFERIEUR ET X A UNE VALEUR DE 0 A 10. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS POUR LE TRAITEMENT DE LA DYSLIPIDEMIE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17782300P | 2000-01-25 | 2000-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN01013A1 true TNSN01013A1 (fr) | 2005-11-10 |
Family
ID=22650106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN01013A TNSN01013A1 (fr) | 2000-01-25 | 2001-01-24 | Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composes |
Country Status (39)
| Country | Link |
|---|---|
| EP (1) | EP1259474B1 (fr) |
| JP (1) | JP4750995B2 (fr) |
| KR (1) | KR20020073182A (fr) |
| CN (1) | CN1395555A (fr) |
| AP (1) | AP2002002587A0 (fr) |
| AR (1) | AR029436A1 (fr) |
| AT (1) | ATE431326T1 (fr) |
| AU (1) | AU2214001A (fr) |
| BG (1) | BG106851A (fr) |
| BR (1) | BR0107763A (fr) |
| CA (1) | CA2397960C (fr) |
| CO (1) | CO5261537A1 (fr) |
| CZ (1) | CZ20022474A3 (fr) |
| DE (1) | DE60138686D1 (fr) |
| DK (1) | DK1259474T3 (fr) |
| DZ (1) | DZ3239A1 (fr) |
| EA (1) | EA004862B1 (fr) |
| EE (1) | EE200200404A (fr) |
| ES (1) | ES2324281T3 (fr) |
| GE (1) | GEP20053428B (fr) |
| GT (1) | GT200100015A (fr) |
| HN (1) | HN2001000011A (fr) |
| HU (1) | HUP0204422A3 (fr) |
| IL (1) | IL150541A0 (fr) |
| IS (1) | IS6442A (fr) |
| MA (1) | MA26867A1 (fr) |
| MX (1) | MXPA02007223A (fr) |
| NO (1) | NO20023526L (fr) |
| NZ (1) | NZ519550A (fr) |
| OA (1) | OA12166A (fr) |
| PA (1) | PA8510601A1 (fr) |
| PE (1) | PE20011064A1 (fr) |
| PL (1) | PL357076A1 (fr) |
| SK (1) | SK10622002A3 (fr) |
| SV (1) | SV2002000290A (fr) |
| TN (1) | TNSN01013A1 (fr) |
| UY (1) | UY26550A1 (fr) |
| WO (1) | WO2001055078A1 (fr) |
| ZA (1) | ZA200205880B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1481962A1 (fr) * | 1997-12-12 | 2004-12-01 | Warner-Lambert Company LLC | Nouveau carboxyéthylether reduisant la cholesterolémie |
| PL375742A1 (en) * | 2002-08-22 | 2005-12-12 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
| US7816405B2 (en) | 2005-04-19 | 2010-10-19 | Eisai R&D Management Co., Ltd. | Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
| EP1873141A4 (fr) * | 2005-04-19 | 2010-09-22 | Eisai R&D Man Co Ltd | Bis[(2s)-3-[3-](2s)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate]de calcium et intermediaire de celui-ci |
| AU2015346037A1 (en) * | 2014-11-14 | 2017-07-06 | Gemphire Therapeutics Inc. | Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers |
| CN110996928A (zh) * | 2017-04-18 | 2020-04-10 | 燿石治疗公司 | 吉卡宾、其药学上可接受的盐、其组合物和其使用方法 |
| US20200253877A1 (en) * | 2018-10-18 | 2020-08-13 | Neurobo Pharmaceuticals, Inc. | Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648387A (en) | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| NZ503982A (en) | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
2001
- 2001-01-11 MX MXPA02007223A patent/MXPA02007223A/es active IP Right Grant
- 2001-01-11 GE GE4872A patent/GEP20053428B/en unknown
- 2001-01-11 CZ CZ20022474A patent/CZ20022474A3/cs unknown
- 2001-01-11 EA EA200200641A patent/EA004862B1/ru not_active IP Right Cessation
- 2001-01-11 CA CA002397960A patent/CA2397960C/fr not_active Expired - Lifetime
- 2001-01-11 ES ES01900037T patent/ES2324281T3/es not_active Expired - Lifetime
- 2001-01-11 IL IL15054101A patent/IL150541A0/xx unknown
- 2001-01-11 AU AU22140/01A patent/AU2214001A/en not_active Abandoned
- 2001-01-11 BR BR0107763-5A patent/BR0107763A/pt not_active IP Right Cessation
- 2001-01-11 WO PCT/IB2001/000026 patent/WO2001055078A1/fr not_active Application Discontinuation
- 2001-01-11 EE EEP200200404A patent/EE200200404A/xx unknown
- 2001-01-11 NZ NZ519550A patent/NZ519550A/en unknown
- 2001-01-11 AT AT01900037T patent/ATE431326T1/de not_active IP Right Cessation
- 2001-01-11 KR KR1020027009519A patent/KR20020073182A/ko not_active Application Discontinuation
- 2001-01-11 HU HU0204422A patent/HUP0204422A3/hu unknown
- 2001-01-11 JP JP2001555021A patent/JP4750995B2/ja not_active Expired - Fee Related
- 2001-01-11 AP APAP/P/2002/002587A patent/AP2002002587A0/en unknown
- 2001-01-11 DE DE60138686T patent/DE60138686D1/de not_active Expired - Lifetime
- 2001-01-11 SK SK1062-2002A patent/SK10622002A3/sk not_active Application Discontinuation
- 2001-01-11 OA OA1200200226A patent/OA12166A/en unknown
- 2001-01-11 DZ DZ013239A patent/DZ3239A1/fr active
- 2001-01-11 EP EP01900037A patent/EP1259474B1/fr not_active Expired - Lifetime
- 2001-01-11 PL PL01357076A patent/PL357076A1/xx not_active Application Discontinuation
- 2001-01-11 DK DK01900037T patent/DK1259474T3/da active
- 2001-01-11 CN CN01804045A patent/CN1395555A/zh active Pending
- 2001-01-22 UY UY26550A patent/UY26550A1/es not_active Application Discontinuation
- 2001-01-22 SV SV2001000290A patent/SV2002000290A/es not_active Application Discontinuation
- 2001-01-23 AR ARP010100284A patent/AR029436A1/es unknown
- 2001-01-23 GT GT200100015A patent/GT200100015A/es unknown
- 2001-01-23 PA PA20018510601A patent/PA8510601A1/es unknown
- 2001-01-24 TN TNTNSN01013A patent/TNSN01013A1/fr unknown
- 2001-01-24 HN HN2001000011A patent/HN2001000011A/es unknown
- 2001-01-24 PE PE2001000076A patent/PE20011064A1/es not_active Application Discontinuation
- 2001-01-24 CO CO01005267A patent/CO5261537A1/es not_active Application Discontinuation
-
2002
- 2002-06-20 BG BG106851A patent/BG106851A/xx unknown
- 2002-06-25 IS IS6442A patent/IS6442A/is unknown
- 2002-07-22 MA MA26735A patent/MA26867A1/fr unknown
- 2002-07-23 ZA ZA200205880A patent/ZA200205880B/xx unknown
- 2002-07-24 NO NO20023526A patent/NO20023526L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN98019A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN99156A1 (fr) | Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN01100A1 (fr) | Derives de glutaramide a substituant cyclopentyle, procede pour leur preparation et compositions les contenant | |
| CN101084224B (zh) | 具有杀真菌活性的噻吩并-嘧啶化合物 | |
| TNSN98025A1 (fr) | Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant. | |
| TNSN97145A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98112A1 (fr) | Composes dipeptidiques | |
| TNSN97070A1 (fr) | Derives d'imidazole substitues, procede pour leur preparation, et compositions les contenant | |
| TNSN97192A1 (fr) | Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| FR2439189A1 (fr) | Nouveaux derives de la 5h-2,3-benzodiazepine et procede pour la preparation de ces derives et compositions pharmaceutiques les contenant | |
| TNSN99073A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN03143A1 (fr) | Ligands de recepteurs de 5-ht et leurs utilisations . | |
| TNSN97197A1 (fr) | Derives de pyrazole parasiticides, procede pour leur preparation et compositions les contenant. | |
| TNSN98238A1 (fr) | Macrolides nouveaux | |
| TNSN98127A1 (fr) | Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN98194A1 (fr) | Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN01046A1 (fr) | Ethers de diphenyle utiles en therapeutique | |
| TNSN99013A1 (fr) | Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98185A1 (fr) | Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN01013A1 (fr) | Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composes | |
| TNSN01094A1 (fr) | Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant | |
| TNSN98196A1 (fr) | Derives d'erythromycine tricycliques nouveaux, procede pour leur preparation et compositions les contenant | |
| FR2437785A1 (fr) | Produit algicide et procede pour prevenir ou combattre des algues avec ce produit, ainsi que de nouvelles diamines et leur preparation | |
| US5523324A (en) | Composition | |
| TNSN00034A1 (fr) | Derives de 2-aminopyridine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |